Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.

Inclusion Criteria: * Adult patients hospitalized in critical cardiac unit care or Intensive care unit for a cardiogenic shock * "Who must have been or is on catecholamines for at least 12 hours for the treatment of cardiogenic shock. * Patients who are able to take oral tablets Exclusion Criteria: * GFR\< 20 ml/min/1.73m2. * Chronic dialysis. * Patient on SGLT2 inhibitors prior to admission to ICU or CCU. * Known allergy to SGLT2 inhibitors or to any of its excipients (in particular, patients with hereditary disorders of galactose intolerance, total lactase deficiency or glucose or galactose malabsorption syndrome) * Patients on lithium. * Patient in shock for another cause or moribund (SAPS2\> 90). * Specific cardiogenic shock context: 1. cardiac transplant patient or on transplant list. 2. peripartum, adrenergic, valvular, non ischemic, post embolic heart disease. 3. related to cardiotropic drug intoxication. 4. Secondary to a cardiac arrest for which the patient remains comatose prior to inclusion. * Women of childbearing age without effective contraception. * Person referred to in Articles 10, 31, 32, 33 and 34 of EU Regulation 536/2014 (Pregnant woman, parturient or breastfeeding mother, Minor (not emancipated), Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice))